GentiBio's proprietary autologous and allogeneic EngTregs platform integrates key complimentary technologies needed to successfully restore immune tolerance and overcome major limitations in existing regulatory T-cell therapeutics.
Boston, Massachusetts US
Synthetic Cells Tissues and Beyond
Founded in 2019, Oxfordshire, United Kingdom
© BioTechScope Ltd. All rights reserved